Federal Court of Australia
FEDERAL COURT OF AUSTRALIA
Reckitt Benckiser Healthcare (UK) Ltd v Glaxosmithkline Australia Pty Ltd (No 4) [2014] FCA 810 Citation: Reckitt Benckiser Healthcare (UK) Ltd v Glaxosmithkline Australia Pty Ltd (No 4) [2014] FCA 810
Parties: RECKITT BENCKISER HEALTHCARE (UK) LIMITED v GLAXOSMITHKLINE AUSTRALIA PTY LTD ABN 47 100 162 481
File number: NSD 734 of 2013
Judge: RARES J
Date of judgment: 3 June 2014
Legislation: Evidence Act 1995 (Cth) Federal Court Rules 1979 (Cth) Federal Court Rules 2011 (Cth)
Cases cited: GlaxoSmithKline Australia Pty Ltd v Reckitt Benckiser Healthcare (UK) Ltd (2013) 305 ALR 363 referred to Lexmark International Inc v Boomerang Imaging Supplies Pty Limited (2001) 112 FCR 331 applied Reckitt Benckiser Healthcare (UK) Ltd v GlaxoSmithKline Australia Pty Ltd (No 2) (2013) 103 IPR 472 referred to
Date of hearing: 3 June 2014
Place: Sydney
Division: GENERAL DIVISION
Category: No catchwords
Number of paragraphs: 13
Counsel for the Applicant: Ms K S Howard SC with Mr J S Cooke and Ms R White
Solicitor for the Applicant: Corrs Chambers Westgarth
Counsel for the Respondent: Mr R J Webb SC with Mr H P T Bevan
Solicitor for the Respondent: Norton Rose Fulbright Australia
IN THE FEDERAL COURT OF AUSTRALIA NEW SOUTH WALES DISTRICT REGISTRY GENERAL DIVISION NSD 734 of 2013
BETWEEN: RECKITT BENCKISER HEALTHCARE (UK) LIMITED
Applicants
AND: GLAXOSMITHKLINE AUSTRALIA PTY LTD ABN 47 100 162 481
Respondent
We try to embed the page this law was scraped from. If the site blocks framing, you still get the link and a local excerpt.
Last checked with source on —
Checking whether the official page can be embedded…
Plain-English simplify of this law: a short summary, key points, and both sides of the argument. Generated on first view via Replicate, then cached. Vote on what helps your study.
No study brief is cached for this law yet. Sign up to generate a plain-English brief.
Sign up to generate